ADVANCED BIOMED INC (ADVB) Stock Price, Forecast & Analysis

NASDAQ:ADVB • US00752P1049

0.2401 USD
+0 (+1.09%)
At close: Feb 13, 2026
0.2333 USD
-0.01 (-2.83%)
After Hours: 2/13/2026, 7:51:17 PM

ADVB Key Statistics, Chart & Performance

Key Statistics
Market Cap5.20M
Revenue(TTM)N/A
Net Income(TTM)-3.38M
Shares21.64M
Float4.86M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.16
PEN/A
Fwd PEN/A
Earnings (Next)04-13
IPO2025-03-06
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
ADVB short term performance overview.The bars show the price performance of ADVB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

ADVB long term performance overview.The bars show the price performance of ADVB in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ADVB is 0.2401 USD. In the past month the price decreased by -24.19%.

ADVANCED BIOMED INC / ADVB Daily stock chart

ADVB Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
ADVB Full Technical Analysis Report

ADVB Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ADVB. ADVB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ADVB Full Fundamental Analysis Report

ADVB Financial Highlights

Over the last trailing twelve months ADVB reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS decreased by -23.48% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -54.15%
ROE -112.52%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-45.53%
Sales Q2Q%N/A
EPS 1Y (TTM)-23.48%
Revenue 1Y (TTM)N/A
ADVB financials

ADVB Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
ADVB Analyst EstimatesADVB Analyst Ratings

ADVB Ownership

Ownership
Inst Owners1.21%
Ins Owners67.44%
Short Float %4.97%
Short Ratio0.37
ADVB Ownership

ADVB Latest News, Press Relases and Analysis

All ADVB news

ADVB Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
COO COOPER COS INC/THE18.1916.243B
ALGN ALIGN TECHNOLOGY INC16.6713.192B
SOLV SOLVENTUM CORP11.6713.173B
MMSI MERIT MEDICAL SYSTEMS INC19.794.676B
LNTH LANTHEUS HOLDINGS INC12.274.557B
ICUI ICU MEDICAL INC17.673.506B
HAE HAEMONETICS CORP/MASS10.522.679B
XRAY DENTSPLY SIRONA INC8.322.556B
NEOG NEOGEN CORP32.262.342B
UFPT UFP TECHNOLOGIES INC24.521.907B

About ADVB

Company Profile

ADVB logo image Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. The company is headquartered in Reno, Nevada and currently employs 31 full-time employees. The company went IPO on 2025-03-06. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Company Info

ADVANCED BIOMED INC

401 Ryland St, Ste 200-A

Reno NEVADA US

Employees: 31

ADVB Company Website

ADVB Investor Relations

Phone: 1862120510823

ADVANCED BIOMED INC / ADVB FAQ

Can you describe the business of ADVANCED BIOMED INC?

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. The company is headquartered in Reno, Nevada and currently employs 31 full-time employees. The company went IPO on 2025-03-06. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.


What is the current price of ADVB stock?

The current stock price of ADVB is 0.2401 USD. The price increased by 1.09% in the last trading session.


What is the dividend status of ADVANCED BIOMED INC?

ADVB does not pay a dividend.


How is the ChartMill rating for ADVANCED BIOMED INC?

ADVB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is ADVB stock listed?

ADVB stock is listed on the Nasdaq exchange.


What is the GICS sector and industry of ADVB stock?

ADVANCED BIOMED INC (ADVB) operates in the Health Care sector and the Health Care Equipment & Supplies industry.